Product information

From Health Canada

The product monograph is developed by a drug sponsor according to guidelines published by Health Canada that provide direction on the content and format. The veterinary labelling is developed by the drug sponsor according to the Food and Drug Regulations. While Health Canada reviews the product monograph or the veterinary labelling as part of the drug review process, it remains the responsibility of the drug sponsor to ensure that the product monograph or the veterinary labelling is complete and accurate.

Current status:

Cancelled Post Market

Current status date:

2022-02-01

Original market date: See footnote 1

2009-08-18

Lot number: See footnote 2

175081

Expiry date: See footnote 2

2020-10-31

Product name:

ACETYLCYSTEINE INJECTION

Help on accessing alternative formats, such as Portable Document Format (PDF), Microsoft Word and PowerPoint (PPT) files, can be obtained in the alternate format help section.

DIN:

02300435

Product Monograph/Veterinary Labelling:

Date: 2019-08-08 Product monograph/Veterinary Labelling (PDF version ~ 175K)

Company:

TELIGENT OU
Akadeemia Tee 21/5
Tallinn
Harju County
Estonia 12618

Class:

Human

Dosage form(s):

Solution

Route(s) of administration:

Inhalation ,  Intravenous ,  Oral

Number of active ingredient(s):

1

Schedule(s):

Ethical

 

American Hospital Formulary Service (AHFS): See footnote 3

92:12.00 

Anatomical Therapeutic Chemical (ATC): See footnote 4

R05CB01 ACETYLCYSTEINE

Active ingredient group (AIG) number:See footnote5

0100024001

List of active ingredient(s)
Active ingredient(s) See footnote8 Strength
ACETYLCYSTEINE 200 MG / ML
Version 4.0.3

"Page details"

Date modified: